The notion of LDL receptor-mediated endocytosis as a protective mechanism in metabolic disorders such as NAFLD is underscored by the severely inflamed liver phenotype resembling NASH found in LDLR knock-out models[26]. This evidence concerns the gene LDLR and metabolic disease.